Immediate Impact
2 by Nobel laureates 3 from Science/Nature 62 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Bård Indrevoll being referenced
Abstract 5859: HER2-targeted thorium-227 conjugate (HER2-TTC): Efficacy in preclinical models of trastuzumab and T-DM1 resistance
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bård Indrevoll | 197 | 104 | 211 | 17 | 463 | |
| Priya Vishnubhotla | 35 | 87 | 297 | 17 | 487 | |
| Shawn M. Vogen | 92 | 46 | 399 | 14 | 545 | |
| Marina Ripamonti | 111 | 101 | 231 | 17 | 460 | |
| Yukio Ueno | 46 | 41 | 182 | 20 | 468 | |
| Paul A. Aeed | 42 | 80 | 299 | 17 | 528 | |
| Rosalie Matico | 59 | 77 | 329 | 17 | 550 | |
| Nigel D. Staite | 58 | 121 | 126 | 13 | 520 | |
| Yerach Daskal | 46 | 99 | 302 | 17 | 532 | |
| D. Mark Bickett | 30 | 212 | 215 | 14 | 524 | |
| Amit Gandhi | 116 | 114 | 242 | 16 | 539 |
All Works
Login with ORCID to disown or claim papers
Loading papers...